A robust independent predictor of local tumor progression (LTP) and OS after CRLM ablation is the detection of tumor cells expressing Ki-67 in ablation zone biopsy specimens, suggesting that these tumors may harbor ablation resistance mechanisms [149,150,151,152,153]. Here, MKI67 is linked to neoplasm.